Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Have questions about traveling on your program
Research consistently shows that substandard products produce poor or absent results, while quality peptides deliver the expected benefits
Follow good laboratory practice and the safety guidance in the Certificate of Analysis
As this medication class expands, organizations partnering with technology providers like YPrimewhose innovative eCOA platform and flexible product development approach can be tailored to meet specific sponsor requirementsare better positioned to accelerate their development programs while maintaining high-quality standards
Protocol 1: Conservative sub-therapeutic approach Goal: Target inflammation with minimal metabolic impact Starting dose: 0.5 to 1.0 mg tirzepatide weekly Escalation: Increase by 0.25 to 0.5 mg every 4 to 6 weeks based on inflammatory marker response Target maintenance: The lowest dose that produces measurable CRP/IL-6 reduction Monitoring schedule: Baseline: hsCRP, IL-6, complete metabolic panel, body weight Week 4: hsCRP, symptom assessment Week 8: hsCRP, IL-6, body weight Every 8 weeks thereafter: full inflammatory panel Duration: Minimum 12 weeks to assess response, with ongoing reassessment Best for: Normal-weight individuals with elevated inflammatory markers, autoimmune patients who cannot afford weight loss This protocol uses the compounded tirzepatide dosage calculator approach since standard vials are not designed for sub-2.5 mg dosing
